Evaluating effects of Sodium Hyaluronate and four amino acids in oral mucositis preventio
Phase 3
- Conditions
- oral mucositis.Oral mucositis (ulcerative), unspecifiedK12.30
- Registration Number
- IRCT20190917044805N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age below 18 years old
Undergoing allogenic hematopeitic stem cell transplantation
Exclusion Criteria
Patients with active oral mucositis at the time of admission
History of hypersensitivity reactions to mucosamine spray or any of its ingreedients
Patients with the diagnosis of fanconie's anemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oral mucositis severity. Timepoint: every other day, since the day of admission till the day of discharge. Method of measurement: National Cancer Institute Common Terminology of Adverse Events criteria version 5.
- Secondary Outcome Measures
Name Time Method Mucositis incidence. Timepoint: Every other day. Method of measurement: Observation.